Purchase Order 36C25023P1444
Award Date
7/1/23
Potential Completion Date
12/31/23
Potential Value
$76K
Federal Agency
Veterans Integrated Service Network 10
Awardee
Sofie CO.
Ultimate Awardee
Sofie Biosciences, Inc.
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Sterling, VA, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Veterans Affairs Veterans Health Administration awarded a $176,398.24 firm fixed price purchase order to Sofie CO. for the delivery of the radiopharmaceutical PYLARIFY. The contract has a completion date of May 31, 2022 and does not utilize a set-aside designation. Sofie CO. is a for-profit organization that specializes in developing and delivering molecular diagnostics and therapeutics, with extensive experience in PET imaging. The company has received multiple federal...
The Department of Veterans Affairs (VA) Veterans Health Administration awarded a $1,172,834.00 firm-fixed-price delivery order contract to Sofie CO., doing business as Sofie, a subsidiary of Sofie Biosciences, Inc. The contract is for the supply of the radiopharmaceutical PYLARIFY F-18 DCFPYL, a molecular diagnostic for prostate cancer detection. The contract has a period of performance through May 31, 2025. Sofie CO. is an experienced prime contractor providing radiopharmaceuticals,...
This is a federal purchase order awarded by the Department of Veterans Affairs (VA) to Sofie CO., doing business as Sofie, a subsidiary of Sofie Biosciences, Inc. The contract is for the supply of the radiopharmaceutical F19, with a ceiling value of $17,535.00 and a period of performance ending on June 30, 2022. The contract has no set-aside designation. Sofie is a specialized provider of radiopharmaceuticals, pharmaceuticals, and related services to various federal agencies, including the VA,...
This is a federal delivery order contract awarded by the Department of Veterans Affairs (VA) to Sofie CO., doing business as Sofie, for the supply of PYLARIFY F-18 isotopes. The contract has a ceiling value of $902,180.00 and runs through August 31, 2029. Sofie is a subsidiary of Sofie Biosciences, Inc. and specializes in the development and delivery of molecular diagnostics and therapeutics, particularly radiopharmaceuticals for medical imaging and cancer treatment. The contract supports the...
The Department of Veterans Affairs Veterans Health Administration awarded a $1.37 million firm fixed price purchase order to Sofie CO., doing business as Sofie, for the delivery of Pylarify radiopharmaceutical isotopes for prostate cancer patients. The contract supports the Special Notice published by VA Network Contracting Office 2 announcing sole source award to Progenics Pharmaceuticals, Inc. through their distributor Sofie. The award aims to provide Pylarify, a prostate-specific membrane...
This federal contract award to Sofie CO., a subsidiary of Sofie Biosciences, Inc., provides PET/CT radiopharmaceuticals to the Department of Veterans Affairs (VA). The $2,343,583.08 fixed-price contract was set aside for small businesses and is scheduled for completion by September 30, 2023. Sofie CO. is a specialized manufacturer and supplier of molecular diagnostics and therapeutics, with extensive experience in positron emission tomography (PET) imaging. The company has been a key provider of...
This is a firm fixed-price purchase order awarded by the Veterans Integrated Service Network 16 (VISN 16) of the U.S. Department of Veterans Affairs (VA) to Sofie CO., doing business as Sofie. The contract, valued at $690,810.00, is for the supply of FDG-F18 radiopharmaceuticals. Sofie is a subsidiary of Sofie Biosciences, Inc. that specializes in the development and delivery of molecular diagnostics and therapeutics, including radiopharmaceuticals for medical imaging and cancer treatment. The...
Sofie Co., a subsidiary of Sofie Biosciences, Inc., was awarded a $453,128 firm fixed price delivery order against the VHA Pharmaceutical Prime Vendor contract to provide Pylarify Piflufolastat F18 radiopharmaceuticals for the Veterans Integrated Service Network 12 region. The one year contract runs from October 2021 through July 2022 and has no set aside designation. The Department of Veterans Affairs Veterans Health Administration will utilize the radiopharmaceuticals in medical imaging...
This is a firm fixed-price purchase order awarded by the Veterans Integrated Service Network 4 (VISN 4) of the Department of Veterans Affairs (VA) to Sofie CO., a subsidiary of Sofie Biosciences, Inc. The contract, valued at $663,619.64, is for the supply of radiopharmaceuticals to support medical imaging and cancer treatment programs for veterans. Sofie is an experienced provider of specialized imaging agents, prostate cancer detection tools, and injectable cancer drugs to the VA, the Defense...
The Department of Veterans Affairs (VA) awarded a $1,198,895.04 firm fixed-price purchase order contract to Sofie CO., a small business prime contractor, for the purchase and delivery of the radiopharmaceutical PYLARIFY (Piflufolastat F-18 Injection) over a one-year period. This contract supports the VA's Veterans Health Administration and Veterans Integrated Service Network 5 for radiology services at the DC VA Medical Center. Sofie CO., a subsidiary of Sofie Biosciences, Inc., is an...